The Latest Breaking News from Novo Nordisk

The European Medicines Agency is looking at Wegovy (semaglutide), Saxenda (liraglutide) and other similar drugs used to control appetite.

Three cases of suicidal and self-harm thoughts identified in Iceland, regulator says

“We're experiencing something here that is very, very different, very exciting from a healthcare perspective, and very expensive,” says Aon's Michael Manolakis.

Hugely popular Weight-loss drug Wegovy helps people achieve weight loss, but many have discontinued due to severe nausea

Losing significant amounts of weight may soon be as easy as taking a daily pill

Novo Nordisk is investing in obesity prevention, the 'real big frontier' of weight loss.

Diabetes is a growing concern as more of the globe becomes modernized and with that is eating a diet that too often is a road to diabetes. Gladly there are drug companies at the forefront of this movement to stem the tide like Novo Nordisk (NVO) making it a very…

A few years ago, celebrity weight-control practices were out of most people’s reach. Live-in chefs and personal trainers, not to mention elaborate surgical procedures like the Brazilian butt lift, were not real options for most. But with the advent of drugs such as semaglutide, it seems that anyone can go…

As Wegovy is set to be available on prescription in the UK, we asked doctors what they think of the controversial weight loss injections

The pharmaceutical sector performs relatively well during economic uncertainties due to inelastic demand for its products and services. While prominent players Tilray Brands (TLRY) and Novo Nordisk (NVO) should benefit, which stock is the better buy now? Read more to find out.

The tennis champion shared her decision to take this step was multi-faceted and motivated by a desire to "be at a healthy place."